
BPC-157 + TB-500 Blend
Research-grade BPC-157 + TB-500 synergistic healing blend 10mg lyophilised powder. 99.0% HPLC purity, COA verified. Combined tissue repair and anti-inflammatory research formula.
We've stocked up — ready for next-day dispatch Australia-wide.
Your cart is empty
Add some research peptides to get started.

Dispatching Friday!
Only 0 in stock. 0 will ship immediately — 1 will be fulfilled as a pre-order.
✓Free shipping on orders over $199 AUD
✓Australia Post tracked — Standard $9.99 / Express $14.99
✓Dispatched next business day (orders before 11PM AEST)
CJC-1295 + Ipamorelin blend is available in Australia from Peptide Warehouse with fast domestic shipping to all states and territories.
This pre-blended combination brings together two of the most popular growth hormone research peptides in a single convenient vial. CJC-1295 works by amplifying the size and duration of natural GH pulses from the pituitary. Ipamorelin works by triggering those pulses in the first place. Because they work on completely different hormone receptors, they complement each other perfectly — researchers consistently find that the combination produces larger, longer-lasting GH responses than either peptide can achieve on its own, without raising stress hormones like cortisol.
Supplied as lyophilised powder at 99.0% HPLC purity, independently verified by third-party testing. 10mg per vial (5mg CJC-1295 + 5mg Ipamorelin). Fast domestic shipping across Australia from our Melbourne warehouse — batch-specific COA available in our COA Library.
⚠ For in-vitro research and laboratory use only. Not for human consumption.
CJC-1295 and Ipamorelin activate separate receptor systems in the GH axis — GHRH receptors and GHS-R1a (ghrelin) receptors respectively. Because there is no receptor overlap and no competition between the two, they work simultaneously and produce synergistic GH output. Research models consistently show that the combined GH pulse from both peptides is larger and more sustained than either alone. The combination is now the most widely used dual GH secretagogue protocol in peptide research, studied for body composition, recovery, sleep quality, and anti-ageing applications. Not for human consumption — for research use only.
CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF 1-29) is a truncated, tetra-substituted GHRH analogue with a half-life of approximately 30 minutes. It mimics physiological pulsatile GHRH signalling, triggering discrete GH pulses. CJC-1295 with DAC includes a Drug Affinity Complex modification that binds plasma albumin, extending the half-life to 6–8 days and creating a prolonged, non-pulsatile GHRH signal. Our blend uses CJC-1295 without DAC to preserve the pulsatile GH release pattern most relevant to physiological GH axis research. Not for human consumption — for research use only.
The pre-blended format offers three advantages: convenience (single reconstitution vs two separate vials), consistency (co-lyophilised peptides are uniformly distributed so each draw contains the correct 1:1 ratio), and cost-efficiency. The blend is ideal for researchers following a fixed 1:1 CJC-1295:Ipamorelin protocol. Researchers requiring asymmetric ratios or independent dosing schedules of each compound should purchase [Ipamorelin 10mg](/products/ipamorelin-10mg) separately. Not for human consumption — for research use only.
Reconstitution: Draw 1–2mL of bacteriostatic water into a clean 31G insulin syringe. Inject slowly down the inside wall of the blend vial. Gently swirl until fully dissolved — do not shake. The solution should be clear and colourless. With 1mL BAC water: 10mg/mL total (5mg/mL CJC-1295 + 5mg/mL Ipamorelin). Storage: Lyophilised — store at −20°C for up to 24 months. Reconstituted — refrigerate at 2–8°C and use within 28 days. Our [BAC Water 10mL](/products/bac-water-10ml) and [Insulin Needles 31G](/products/insulin-needles-31g) are available for a complete setup.
Both CJC-1295 and Ipamorelin are legal to purchase in Australia for legitimate laboratory research purposes. Neither is listed as a scheduled substance under the Poisons Standard when sold for research use only. Purchasers must be 18+ and confirm research-only use. These compounds are not TGA-approved for human consumption, therapeutic, or veterinary use. Our blend is independently verified at 99.0% HPLC purity with full COA documentation.
Peptide Warehouse dispatches CJC-1295 + Ipamorelin nationwide via Australia Post with full tracking from our Melbourne warehouse. Orders placed before 11PM AEST dispatch the next business day. Standard Post (2–6 business days) $9.99; Express Post (1–3 business days) $15.99. Free shipping on orders over $199 AUD. All orders are shipped in discreet plain packaging.
The CJC-1295 + Ipamorelin combination is used in GH axis research including: pulsatile GH secretion quantification and IGF-1 elevation studies, body composition research in rodent models (lean mass and fat metabolism), sleep architecture and nocturnal GH pulse timing experiments, age-related GH decline (somatopause) research, muscle and connective tissue recovery models, and metabolic rate and lipolysis pathway investigations. The combination is the standard dual-pathway GH secretagogue protocol in preclinical and in-vitro research. Not for human consumption — for research use only.
CJC-1295 without DAC (Modified GRF 1-29) has a molecular weight of approximately 3367.9 Da. It is a 29-amino acid GHRH analogue with four amino acid substitutions at positions 2, 8, 15, and 27 to improve metabolic stability. The companion Ipamorelin has CAS 170851-70-4 and MW 711.85 Da. Both are confirmed via mass spectrometry in the COA. Not for human consumption — for research use only.

Research-grade BPC-157 + TB-500 synergistic healing blend 10mg lyophilised powder. 99.0% HPLC purity, COA verified. Combined tissue repair and anti-inflammatory research formula.

KLOW multi-peptide blend 80mg lyophilised powder. 99.0% HPLC purity, COA available online. Advanced synergistic peptide research formula.